Abstract：2019 novel coronavirus (SARS-CoV-2) invades the human body and causes an acute respiratory infectious disease, which was named as Corona Virus Disease (COVID-19). The global spread of SARS-Cov-2 poses a huge threat to global public health security. The detection of SARS-CoV-2 is particularly important for disease diagnosis. Immunoassay method has played a role in clinical diagnosis as an aid to virus nucleic acid detection. Immuno-diagnostic techniques include antibody and antigen detection, and determine whether the virus are carried by detecting the viruss own protein and antibody. Analysis was focused on the current immunoassay methods for SARS-CoV-2.
［1］Ramaiah A, Arumugaswami V. Insights into Cross-species Evolution of Novel HumanCoronavirus 2019-nCoV and Defining Immune Determinants for Vaccine Development［J］. bioRxiv, 2020. https://doi.org/10.1101/2020.01.29.925867.
［2］张永卓, 王晶, 傅博强, 等. 2019新型冠状病毒的核酸检测［J］.计量学报, 2020, 41(4): 393-398.
Zhang Y Z, Wang J,Fu B Q, et al. Nucleic Acid Detection of the SARS-CoV-2［J］.Acta Metrologica Sinica, 2020,41(4): 393-398.
［3］Shen M Z, Zhou Y, Ye J W, et al. Recent advances and perspectives of nucleic acid detection forcoronavirus［J］. Journal of Pharmaceutical Analysis, 2020. https://doi.org/10.1016/j.jpha.2020.02.010.
［4］Peng L, Liu J, Xu W X, et al. 2019 Novel Coronavirus can be detected in urine, blood, anal swabs and oropharyngeal swabs samples［J］. medRxiv. https://doi.org/10.1101/2020.02.21.20026179.
［5］Zhou P, Yang X L, Wang X G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin ［J］. Nature, 2020, 579: 270-273.
［6］Xiao S Y, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring ［J］. Journal of Medical Virology, 2020, 92(5):1-4.
［7］Jia X, Zhang P, Tian Y. Clinical significance of IgM and IgG test for diagnosis of highly suspected COVID-19 infection［J］. medRxiv. https://doi.org/10.1101/2020.02.28.20029025.
［8］Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019［J］. medRxiv. https://doi.org/10.1101/2020.03.02.20030189.
［9］Zhang J, Liu J, Li N, et al. Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing［J］. medRxiv. https://doi.org/10.1101/2020.03.04.20030916.
［10］Cai X, Chen J, Hu J, et al. A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Corona Virus Disease 2019 (COVID-19) ［J］. medRxiv.https://doi.org/10.1101/2020.02.22.20026617.
［11］Li M, Jin R, Peng Y, et al. Generation of antibodies against COVID-19 virus for development of diagnostic tools ［J］. medRxiv. https://doi.org/10.1101/2020.02.20.20025999.
［12］Wan Y S, Shang J, Graham R, et al. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS ［J］. Journal of Virology,2020,doi:10. 1128/JVI. 00127-20.
［13］Lei C H, Fu W Y, Qian K W, et al. Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig ［J］. bioRxiv.https://doi.org/10.1101/2020.02.01.929976.
［14］Tian X L, Li C, Huang A L, et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody［J］. bioRxiv. https://doi.org/10.1101/2020.01.28.923011.
［15］Xiang J, Yan M, Li H, et al. Evaluation of Enzyme-Linked Immunoassay and Colloidal GoldImmunochroma-tographic Assay Kit for Detection of Novel Coronavirus (SARS-Cov-2) Causing an Outbreak of Pneumonia (COVID-19) ［J］. medRxiv. https://doi.org/10.1101/2020.01.29.925867.
2020, Vol. 41 
